Aperio Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
ACH
AAM
GL
SGCM
PCM
Aperio Group's BEAT Position: Q4 2020 in Review
Aperio Group reduced its BioTelemetry, Inc. (BEAT) stake by 3.8% in Q4 2020, selling an estimated $55.9K and leaving 26,968 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #1247.
Aperio Group first reported a position in BEAT in Q2 2017 and has held it in 15 quarters since. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.
- Aperio Group held 26,968 shares of BioTelemetry, Inc. worth $1.94M as of Q4 2020.
- Aperio Group sold 1,068 BioTelemetry, Inc. shares in Q4 2020, an estimated $55.9K.
- BioTelemetry, Inc. made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1247 holding.
- Aperio Group first reported a position in BioTelemetry, Inc. in Q2 2017 and has held it in 15 quarters since.
- 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.